PS
Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
801
TFS Financial
TFSL
$3.74B
|
AB
Adam Butler
| $13.34 | $15 |
12%
upside
| Neutral |
22 Nov ‘24
9 months ago |
|
802
Sunrun
RUN
$3.72B
|
KH
Kashy Harrison
| $16.13 | $11 |
32%
downside
| Neutral |
22 Nov ‘24
9 months ago |
|
803
Aclaris Therapeutics
ACRS
$225M
|
CR
Christopher Raymond
| $2.08 | $13 |
525%
upside
| Overweight |
18 Nov ‘24
9 months ago |
|
804
Dine Brands
DIN
$358M
|
BM
Brian Mullan
| $23.30 | $38 |
63%
upside
| Neutral |
18 Nov ‘24
9 months ago |
|
805
Moderna
MRNA
$9.6B
|
ET
Edward Tenthoff
| $24.67 | $69 |
180%
upside
| Overweight |
18 Nov ‘24
9 months ago |
|
806
Travere Therapeutics
TVTX
$2.41B
|
AB
Allison Bratzel
| $27.06 | $22 |
19%
downside
| Neutral |
14 Nov ‘24
10 months ago |
|
807
Rigel Pharmaceuticals
RIGL
$670M
|
AB
Allison Bratzel
| $37.33 | $23 |
38%
downside
| Neutral |
14 Nov ‘24
10 months ago |
|
808
Rocket Companies
RKT
$44B
|
BC
Brad Capuzzi
| $20.93 | $16 |
24%
downside
| Neutral |
14 Nov ‘24
10 months ago |
|
809
Immunome
IMNM
$810M
|
BA
Biren Amin
| $9.30 | $21 |
126%
upside
| Overweight |
14 Nov ‘24
10 months ago |
|
810
Maplebear
CART
$12.3B
|
TC
Thomas Champion
| $46.85 | $58 |
24%
upside
| Overweight |
13 Nov ‘24
10 months ago |
|
811
Integral Ad Science
IAS
$1.41B
|
MF
Matt Farrell
| $8.49 | $16 |
88%
upside
| Overweight |
13 Nov ‘24
10 months ago |
|
812
Spotify
SPOT
$146B
|
MF
Matt Farrell
| $707.67 | $450 |
36%
downside
| Neutral |
13 Nov ‘24
10 months ago |
|
813
Tempest Therapeutics
TPST
$46.8M
|
ET
Edward Tenthoff
| $10.53 | $65 |
517%
upside
| Overweight |
13 Nov ‘24
10 months ago |
|
814
American Financial Group
AFG
$11.4B
|
PN
Paul Newsome
| $137.03 | $150 |
9%
upside
| Neutral |
12 Nov ‘24
10 months ago |
|
815
First Watch Restaurant Group
FWRG
$1.07B
|
NMR
Nicole Miller Regan
| $17.61 | $23 |
31%
upside
| Overweight |
11 Nov ‘24
10 months ago |
|
816
Bloomin' Brands
BLMN
$580M
|
BM
Brian Mullan
| $6.82 | $16 |
135%
upside
| Neutral |
11 Nov ‘24
10 months ago |
|
817
Amneal Pharmaceuticals
AMRX
$3.1B
|
DA
David Amsellem
| $9.86 | $11 |
12%
upside
| Overweight |
11 Nov ‘24
10 months ago |
|
818
Avita Medical
RCEL
$112M
|
MO
Matt O'Brien
| $4.13 | $12 |
191%
upside
| Neutral |
8 Nov ‘24
10 months ago |
|
819
Vivid Seats
SEAT
$97M
|
MF
Matt Farrell
| $14.99 | $80 |
434%
upside
| Neutral |
8 Nov ‘24
10 months ago |
|
820
Arcellx
ACLX
$3.9B
|
BA
Biren Amin
| $70.39 | $115 |
63%
upside
| Overweight |
8 Nov ‘24
10 months ago |
|
821
MDxHealth
MDXH
$172M
|
JB
Jason Bednar
| $3.48 | $6 |
72%
upside
| Overweight |
7 Nov ‘24
10 months ago |
|
822
Revolution Medicines
RVMD
$7.57B
|
JC
Joseph Catanzaro
| $40.48 | $70 |
73%
upside
| Overweight |
7 Nov ‘24
10 months ago |
|
823
Kura Sushi USA
KRUS
$967M
|
BM
Brian Mullan
| $79.98 | $98 |
23%
upside
| Neutral |
7 Nov ‘24
10 months ago |
|
824
Upwork
UPWK
$2.14B
|
MF
Matt Farrell
| $16.13 | $18 |
12%
upside
| Overweight |
7 Nov ‘24
10 months ago |
|
825
Q2 Holdings
QTWO
$5.2B
|
AR
Arvind Ramnani
| $83.22 | $93 |
12%
upside
| Neutral |
7 Nov ‘24
10 months ago |
|